(Q47251534)

English

Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size

scientific article published in December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Abe J

1

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Urano T

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Konno H

3

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Erhan Y

4

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Tanaka T

5

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Nishino N

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Takada A

7

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Nakamura S

8

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

86

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

12

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

2602-2611

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

The role of proteolytic enzymes in cancer invasion and metastasis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Plasminogen Activation by Receptor-Bound Urokinase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Antibodies to plasminogen activator inhibit human tumor metastasis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Plasminogen activator system in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Excess soluble urokinase-type plasminogen activator receptor in the plasma of patients with paroxysmal nocturnal hemoglobinuria inhibits cell-associated fibrinolytic activity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2602%3A%3AAID-CNCR4%3E3.0.CO%3B2-S

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19991215)86:12<2602::AID-CNCR4>3.0.CO;2-S

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10594855

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47251534&oldid=2147997439"